Scott, W G <br/><br/>
Pharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study.  [electronic resource] 

 -  Infection  1995 
 - S21-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0300-8126 
<br/><br/><label>Standard No.: </label>10.1007/BF02464955  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Amoxicillin--economics<br/>Amoxicillin-Potassium Clavulanate Combination<br/>Clavulanic Acids--economics<br/>Cost-Benefit Analysis<br/>Drug Therapy, Combination--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Respiratory Tract Infections--drug therapy<br/>Roxithromycin--economics